These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 429267)

  • 1. Stimulation of catalase synthesis and increase of carnitine acetyltransferase activity in the liver of intact female rats fed clofibrate.
    Reddy JK; Kumar NS
    J Biochem; 1979 Mar; 85(3):847-56. PubMed ID: 429267
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 3. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
    Moody DE; Reddy JK
    Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of ethanol and clofibrate on the activity of lipid catabolism enzyme systems in rat liver].
    Antonenko VD; Popova SV; Panchenko LF
    Farmakol Toksikol; 1983; 46(5):86-90. PubMed ID: 6138280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of carnitine acetyltransferase by clofibrate in rat liver.
    Mittal B; Kurup CK
    Biochem J; 1981 Jan; 194(1):249-55. PubMed ID: 6796058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid-induced increase in carnitine acetyltransferase in rat hepatocytes is not due to an induction of peroxisomes.
    Singh Y; Liu GA; Krishna G
    J Toxicol Environ Health; 1987; 22(4):459-69. PubMed ID: 3121863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic and renal effects of peroxisome proliferators: biological implications.
    Reddy JK; Warren JR; Reddy MK; Lalwani ND
    Ann N Y Acad Sci; 1982; 386():81-110. PubMed ID: 7046570
    [No Abstract]   [Full Text] [Related]  

  • 8. Proliferation of microbodies and synthesis of catalase in rat liver. Induction in tumor-bearing host by CPIB.
    Reddy J; Svoboda D
    Am J Pathol; 1971 Apr; 63(1):99-108. PubMed ID: 4323477
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferators.
    Reddy JK; Moody DE; Azarnoff DL; Rao MS
    Proc Soc Exp Biol Med; 1977 Apr; 154(4):483-7. PubMed ID: 859854
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased pivaloylcarnitine in the liver of the sodium pivalate treated rat exposed to clofibrate.
    Diep QN; Bøhmer T
    Biochim Biophys Acta; 1995 May; 1256(2):245-7. PubMed ID: 7766704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of clofibrate on the enzyme activity of the rat small intestine epithelium].
    Antonenkov VD
    Biokhimiia; 1983 May; 48(5):763-7. PubMed ID: 6871286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
    Stevens TJ; Stafford WW; Day CE; Block EM
    Artery; 1983; 12(2):81-94. PubMed ID: 6678582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of clofibrate on the polypeptide content of a purified fraction of rat liver peroxisomes].
    Antonenkov VD; Pirozhkov SV; Panchenko LF
    Biokhimiia; 1983 Sep; 48(9):1429-36. PubMed ID: 6626603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interlobular differences in the changes induced in rat liver by clofibrate and clofenapate.
    Krishnakantha TP; Kurup CK
    Environ Physiol Biochem; 1974; 4(5):243-50. PubMed ID: 4461276
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of clofibrate treatment on hepatic prostaglandin catabolism and action.
    Brass EP; Ruff LJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1034-8. PubMed ID: 2046019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of AY-25,712 and other lipid-lowering agents on liver catalase and liver carnitine acetyltransferase in rats.
    Kallai-Sanfacon MA; Cayen MN; Dubuc J; Greselin E; Dvornik D
    Proc Soc Exp Biol Med; 1983 Jul; 173(3):367-71. PubMed ID: 6867010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subcellular localization of carnitine acetyltransferase in the organs of intact and starving rats].
    Lebkova NP
    Biull Eksp Biol Med; 1983 Jul; 96(7):32-5. PubMed ID: 6871452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of clofibrate on intracellular enzyme distribution in the rat liver].
    Panchenko LF; Popova SV; Pirozhkov SV; Antonenkov VD
    Tsitologiia; 1983 Nov; 25(11):1302-8. PubMed ID: 6659071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.
    Paul HS; Adibi SA
    J Clin Invest; 1979 Aug; 64(2):405-12. PubMed ID: 457859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.